The costs of COVID-19 and the cost-effectiveness of testing
Purpose – This paper aims to provide an estimation of the costs of the coronavirus (COVID-19) pandemic with a special focus on Spain. Costs include macroeconomic costs of foregone gross domestic product (GDP) attributable to the pandemic and the direct and indirect costs of prevention, treatment and...
Main Authors: | Beatriz González López-Valcárcel, Laura Vallejo-Torres |
---|---|
Format: | Article |
Language: | English |
Published: |
Emerald Publishing
2021-04-01
|
Series: | Applied Economic Analysis |
Subjects: | |
Online Access: | https://www.emerald.com/insight/content/doi/10.1108/AEA-11-2020-0162/full/pdf |
Similar Items
-
COVID-19 in real world: Survival and medical costs of hospitalized patients in Brazil´s first wave
by: Jaime Luís Lopes Rocha, et al.
Published: (2023-07-01) -
Benefits, risks, and cost-effectiveness of COVID-19 self-tests from a consumer’s perspective
by: Afschin Gandjour
Published: (2022-01-01) -
Cost of illness studies in COVID-19: a scoping review
by: Majid Nakhaee, et al.
Published: (2024-01-01) -
Cost-effectiveness analysis of isolation strategies for asymptomatic and mild symptom COVID-19 patients
by: Unyaporn Suthutvoravut, et al.
Published: (2023-11-01) -
Cost-effectiveness analysis of COVID-19 vaccination in Poland
by: Katarzyna Orlewska, et al.
Published: (2021-12-01)